Mumbai, Nov. 24
Zydus Cadila has filed an Investigational New Drug (IND) application with the Drug Controller General of India for the new molecular entity ZY01, a drug candidate for treating obesity and related disorders.
ZYO1 is an experimental drug to help obese patients lose weight and control blood sugar levels in type-2 diabetes.
"ZYO1 has shown remarkable efficacy and a clean toxicity profile in pre-clinical trials. It holds promising commercial potential in the absence of effective treatments for obesity and related disorders," said Mr Pankaj Patel, Chairman and Managing Director of Zydus Cadila. Zydus Cadila plans to initiate clinical trials to ensure the safety and tolerability of ZYO1.